435 (Metformin 850 mg)
Pill imprint 435 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 435
- 850 mg
- 12.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|63739-0300||McKesson Packaging Services|
|67544-0107||Prepak Systems Inc (repackager)|
|55887-0614||Diversified Healthcare Services Inc (repackager)|
|21695-0472||Rebel Distributors Corp (repackager)|
|55289-0934||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about metformin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.